Stock Detail
CARACO PHARMACEUTICAL LABORATORIES LTD
Drugs - Generic
CPD @ Yahoo Finance | CPD Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $5.19 | $5.20 | $-0.02 | -0.38% | 0.00 | $5.21 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $5.20 | $5.19 | 27,982 | 208.73M | 54,212.5 | -34.60 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 5.20 | 5.19 | 5.19 | 5.18 | 5.18 |
Stock Profile
Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, and marketing of generic, prescription, and over-the-counter pharmaceuticals in the United States. The company offers drugs relating to various therapeutic segments, such as central nervous system, cardiology, pain management, and diabetes. Its product portfolio comprises Metroprolol Tartrate for hyper-tension, Paromomycin Sulfate antibacterial product, Salsalate decongestant, CMT for Arthritis/NSAID, and Clonazepam for seizure and panic disorders. The company's portfolio also includes Flurbiprofen for Arthritis/NSAID, Carbamazepine for epilepsy, Oxaprozin for Rheumatoid disease, Metformin Hydrochloride for diabetes, Ticlopidine for reduction of incidence of strokes, and Digoxin for heart failure. As of March 31, 2005, its product portfolio comprised 17 prescription products in 36 strengths in 89 package sizes. Caraco Pharmaceutical markets it products through wholesalers, buying groups, retail pharmacies, and hospitals. The company was organized in 1984 and is based in Detroit, Michigan. Caraco Pharmaceutical Laboratories, Ltd. is a subsidiary of Sun Pharmaceutical Industries Limited.